
European Respiratory Society - ERS International Congress
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to European Respiratory Society - ERS International Congress — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
European Respiratory Society (ERS) International Congress 2026
Event facts (from official source)
- Event name: ERS Congress 2026
- Date: 5–9 September 2026
- Location: Barcelona, Spain
- Venue (hall/convention center name): Not stated in the provided official page text
- Event type (context): Annual international congress focused on respiratory medicine and science; includes registration, abstract/clinical case submission, and continuing medical education (CME) activities
Research objective (what We are targeting)
We are building a buyer-focused attendee/company research view for the ERS Congress 2026, prioritizing organizations that have a practical reason to meet respiratory clinicians, respiratory researchers, allied health professionals, hospital decision-makers, and industry stakeholders active in respiratory care. Since ERS is a medically anchored community, the highest-value buyers typically come from pharmaceuticals, biologics, medical devices, diagnostics, respiratory therapeutics, and respiratory research/clinical trial ecosystems.
1️⃣ Who attends (BUYERS / ATTENDEES)
This is not only a “trade” event; it is a scientific and clinical congress that draws a large respiratory medicine community. The official ERS site describes the broader ERS community as including more than 35,000 clinicians, scientists and allied health professionals from over 160 countries. Translating that into likely congress participation, attendee and buyer relevance clusters into the following groups:
A) Clinical and academic attendees (primary visibility)
- Respiratory physicians / pulmonologists
- Clinician-scientists (physicians doing translational research)
- Researchers focused on airway disease, pulmonary vascular disease, interstitial lung disease, infections, sleep/breathing disorders, thoracic oncology, paediatric respiratory care, respiratory critical care, etc.
- Allied health professionals involved in respiratory care delivery and education (e.g., physiotherapy, respiratory nursing, sleep-related services)
- Medical educators and professionals pursuing CME-related activity
B) Industry stakeholders (the “buyer” layer)
- Pharmaceutical and biotech commercial leadership (market access, medical affairs, respiratory portfolio leadership)
- Medical device and diagnostics business development / marketing
- Clinical research operations and trial ecosystem teams (where relevant—especially for respiratory therapeutics)
- Hospital procurement influencers are less often the “main crowd” at a purely clinical congress, but some buyers show up via clinical networks, specialty relationships, and sponsored sessions
Buyer implication for We: the highest-quality accounts are usually those that already invest in respiratory therapeutic categories (COPD, asthma, ILD, pulmonary hypertension/vascular disease, sleep/breathing disorders, respiratory infections, critical care ventilation interfaces) and that require direct access to respiratory clinicians and research stakeholders.
2️⃣ Where the show is happening + attendee geographic origin
Show location
- City: Barcelona
- Country: Spain
- Date: 5–9 September 2026
- Venue name: Not stated on the provided official text
Attendee geographic origin (what We can support from the provided source)
The ERS community is described as including members from over 160 countries, which strongly indicates global participation across the congress. However, the provided page text does not list specific proportions (e.g., how many attendees are European vs. North America vs. Asia-Pacific) or any nationality breakdown for the congress itself.
Practical targeting conclusion for We:
- Primary bias: Europe-led by ERS’s European society foundation and member footprint
- Strong global representation: the “over 160 countries” indicator suggests international participation beyond Europe
- Best ROI approach: target buyers with international respiratory programs and multinational medical affairs / commercial operations (rather than limiting to local Spain-only organizations)
3️⃣ Audience reach (Local / National / Global)
Based on the official ERS description of community scale and country diversity, ERS Congress has global reach with a strong international clinical/scientific network. The congress is held in Barcelona, Spain, but the audience is not restricted to a single region.
Reach classification for We: Global (international medical + research audience)
4️⃣ Sample buyer company names (BUYERS ONLY) + Websites
Below is a curated set of buyer-style organizations likely to value presence at a respiratory medicine congress. These are organized as a buyer targeting dataset to match roles that manage respiratory portfolios, medical affairs, clinical evidence strategy, medical device/diagnostics adoption, and respiratory research engagement.
Buyer fit table (15–20 samples)
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | GSK (GlaxoSmithKline) | gsk.com | Head of Respiratory Medical Affairs / Medical Director, Respiratory | Direct fit for respiratory therapeutic categories where clinical evidence, KOL engagement, and congress presence matter. |
| 2 | AstraZeneca | astrazeneca.com | Global Medical Affairs Lead (Respiratory) / Medical Director, Respiratory | Strong respiratory franchise relevance; congress participation typically supports clinician education and evidence dissemination. |
| 3 | Sanofi | sanofi.com | Respiratory Medical Affairs Director / Pulmonology Clinical Lead | Respiratory portfolio stakeholders align closely with congress themes across airway disease and related areas. |
| 4 | Novartis | novartis.com | Medical Affairs Director (Pulmonary) / Translational Science Lead | International respiratory research and medical leadership teams benefit from access to clinical-scientific networks. |
| 5 | Boehringer Ingelheim | boehringer-ingelheim.com | Global Medical Affairs Manager, Respiratory / Pulmonary Portfolio Lead | Respiratory medicine focus makes this a highly relevant buyer for congress engagement and evidence-building. |
| 6 | Merck & Co. (MSD) | merck.com | Medical Affairs Director (Respiratory) / Clinical Evidence Lead | Respiratory immunology and evidence strategies often align with major respiratory congress programming. |
| 7 | Roche | roche.com | Global Medical Affairs Lead, Respiratory / Diagnostics Clinical Strategy | Respiratory diagnostics and clinical strategy teams often use major congresses to connect with clinicians and researchers. |
| 8 | AbbVie | abbvie.com | Medical Director, Immunology/Pulmonology / Respiratory Franchise Lead | Strong relevance when immunology and respiratory overlap is a focus in programming and clinical adoption. |
| 9 | Teva Pharmaceuticals | teva.com | Respiratory Business Unit Director / Medical Affairs Lead, Respiratory | Respiratory portfolio stakeholders can use congress visibility for clinical engagement and partner discussions. |
| 10 | Takeda | takeda.com | Medical Affairs Director (Respiratory) / Clinical Development Lead | Therapeutic development and medical leadership teams find direct value in respiratory KOL environments. |
| 11 | Philips | philips.com | Director, Clinical Respiratory Solutions / Market Development Manager | Respiratory care technologies (including sleep/breathing and patient monitoring ecosystem) align strongly with congress themes. |
| 12 | ResMed | resmed.com | EMEA Sales/Business Development Lead (Sleep/Breathing) / Medical Affairs Lead | Sleep and breathing disorders and related respiratory patient pathways create strong congress fit. |
| 13 | Getinge | getinge.com | Respiratory/ICU Solutions Marketing Manager / Clinical Applications Specialist | Respiratory critical care and mechanical ventilation adjacency increases relevance for ICU-focused buyer teams. |
| 14 | Dräger | draeger.com | International Sales Director (Ventilation/ICU) / Clinical Applications Manager | Ventilation and critical care ecosystems often align with respiratory critical care sessions and demonstrator interest. |
| 15 | Hamilton Medical | hamilton-medical.com | Director, Acute Care Solutions / Product Marketing Manager (Ventilation) | Direct alignment with respiratory critical care and mechanical ventilation relevance. |
| 16 | Sysmex | sysmex.com | Diagnostics Medical Affairs / Respiratory Diagnostics Business Lead | Diagnostics companies often benefit from clinician engagement across infection and clinical pathway topics. |
| 17 | Thermo Fisher Scientific | thermofisher.com | Life Sciences Sales Lead / Clinical Research Partnerships Manager | Research ecosystem fit for respiratory science and translational research workflows used by labs and clinical studies. |
| 18 | Amgen | amgen.com | Medical Affairs Director, Respiratory/Immunology / Clinical Strategy Lead | Immunology-related respiratory research and evidence programs often connect to major respiratory medical congresses. |
Top “send first” short list for We (highest relevance mix)
- GSK
- AstraZeneca
- AstraZeneca / (medical affairs respiratory leadership)
- ResMed
- Dräger
- Philips
- Roche (where diagnostics/clinical strategy is relevant)
We recommend starting with a mix of pharmaceutical/biotech respiratory medical affairs plus sleep/breathing and respiratory critical care device ecosystems, since ERS Congress programming spans both clinical and research tracks.
5️⃣ Job profiles, industries & event type
Best job profiles to target (titles that match buyer decision-making)
- Medical Director / Medical Affairs Director (Respiratory)
- Head of Respiratory Medical Affairs
- Global Medical Affairs Lead (Pulmonology / Airway diseases / ILD / Sleep & breathing)
- Clinical Evidence Lead / Clinical Science Leader
- Clinical Development Lead (respiratory program)
- Portfolio Lead / Franchise Lead (Respiratory)
- Market Access / HEOR Lead (where reimbursement strategy is needed)
- Medical Science Liaison (MSL) Manager / MSL Team Lead (respiratory)
- Product Marketing Manager (respiratory devices, ventilation, monitoring, sleep)
- Clinical Applications Specialist (ICU/ventilation)
- Business Development Manager (clinical research partnerships)
- Diagnostics Clinical Strategy / Diagnostics Medical Affairs
Event type classification (for We’s buyer-fit narrative)
- Scientific & clinical congress
- Medical education with CME components
- Respiratory medicine and research agenda (airway, pulmonary vascular, ILD, sleep/breathing, thoracic oncology, infections, paediatric respiratory, respiratory critical care, etc.)
- Industry engagement (industry section exists on the official site, indicating structured industry participation)
Best-fit industries (aligned to the provided industry list)
Using the provided industry categories, We would prioritize:
- Hospital & Health Care
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Research
- Events Services (only for event-industry vendors; main buyers are healthcare/biopharma/device organizations)
- Professional Training & Coaching (if the client product is training/CME-related)
6️⃣ Estimated attendance (expected total footfall)
The provided official page text does not include expected attendance or footfall numbers for ERS Congress 2026. Estimated attendance: Not stated in the provided official website content.
How We would handle this in a buyer-sourcing project: We would avoid guessing counts in deliverables and instead focus on buyer density signals: multinational respiratory portfolios, major therapeutic areas, and the structured presence of industry stakeholders.
7️⃣ Key focus areas & buyer engagement
The official ERS congress context strongly indicates that the congress content spans major respiratory disease domains and clinical practice areas. For buyer engagement, We should map engagement angles to likely congress interests:
Key focus areas (from ERS science/education domains shown on the official site)
- Airway diseases (e.g., asthma/COPD-type clinical contexts)
- Pulmonary vascular diseases
- Sleep and breathing disorders
- Interstitial lung disease
- Respiratory critical care (incl. mechanical ventilation adjacency)
- Thoracic oncology
- Paediatric respiratory diseases
- Respiratory infections
Buyer engagement themes that We would use
- KOL and medical education engagement: medical affairs and clinical evidence teams seeking clinician updates and peer discussion
- Product adoption & clinical pathways: respiratory devices, ventilation/ICU solutions, and monitoring ecosystems benefit from clinician education and implementation discussions
- Translational research & clinical trials ecosystem: life sciences and research tools benefit from partnerships and research community interaction
- Regional expansion (EMEA): the congress host city in Spain makes it convenient for European respiratory stakeholders; multinational accounts have strategic reasons to attend
8️⃣ Client-product fit check (We must align to the client’s buying needs)
We can produce the “best buyer” shortlist only after We understand the client product category precisely. The official page confirms the congress is respiratory-medicine centered, but the right buyers depend entirely on whether the client sells:
- pharmaceutical/biotech respiratory therapies (drug development / medical affairs buyers)
- medical devices or ventilation / monitoring equipment (ICU/respiratory device buyers)
- diagnostics or lab tests (diagnostics medical affairs / clinical strategy buyers)
- research tools/life sciences workflows (research partnerships and sales leads)
- education/training/CME tooling (education/clinical training decision-makers)
We request the client website to finalize buyer recommendations
Please share the client website URL (and, if possible, a 2–3 line product description). Once We have that, We will:
- map the client product to the most relevant ERS congress focus areas (airway, ILD, sleep/breathing, critical care, etc.)
- select the best-fit buyer companies from the buyer table (and expand it if needed)
- recommend the exact job-title targets that match the buying function (medical affairs vs. commercial vs. clinical operations vs. clinical applications)
- provide a prioritized “send first” list and a longer outreach list
Client website: Not provided yet.
9️⃣ Final recommendation (buyer-quality view for ERS Congress 2026)
ERS Congress 2026 in Barcelona (5–9 September 2026) is a high-intent, medically anchored international congress. For buyer discovery and outreach, the event is especially suitable for:
- respiratory pharmaceutical/biotech companies (medical affairs, clinical evidence, portfolio leads)
- respiratory devices / ventilation / sleep & breathing technology companies (clinical applications, product marketing, ICU solutions)
- diagnostics providers and translational research ecosystem organizations
- research/clinical partnership stakeholders aligned with respiratory disease areas
Quality rating for buyer-fit dataset (qualitative): High
Reason: the ERS community is large and globally diverse (over 160 countries), and respiratory domains are clearly defined, which improves relevance of buyer targeting and outreach messaging.
Appendix: Quick buyer-targeting checklist for We
- Prioritize respiratory therapeutic areas and respiratory device/sleep/ICU solution categories
- Target job functions tied to medical affairs, clinical evidence, and clinical applications (not generic roles)
- Use multinational buyer companies with EMEA or global leadership presence
- Refine final “best buyers” once the client website/product category is provided
Data sheet
| Event Name | European Respiratory Society - ERS International Congress |
| Event Date | 5–9 September 2026 |
| Event Status | Upcoming |
| Venue | Not publicly confirmed in the provided official text |
| City | Barcelona |
| State / Region | Catalonia |
| Country | Spain |
| Organizer | European Respiratory Society (ERS) |
| Official Event Website | ERS Congress official website |
| Event Type | International medical congress / scientific conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Education & Training; Business Services |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | High for date, city, organizer, and event identity; attendance volume not publicly confirmed in the provided official text. |
| Main Purpose of Event | To convene global respiratory medicine experts to present research, education, clinical updates, innovation, and professional networking. |
The ERS International Congress is the flagship annual meeting of the European Respiratory Society and is positioned as one of the largest events on the respiratory medicine calendar. It brings together clinicians, scientists, allied health professionals, educators, and industry stakeholders focused on lung health, respiratory care, diagnostics, therapeutics, and scientific advancement.
This congress matters because it concentrates decision-makers and expert practitioners who influence clinical practice, research priorities, product adoption, procurement discussions, and partnership opportunities across respiratory medicine. For exhibitors and solution providers, it is a high-value environment for education-led engagement, medical technology positioning, evidence-based selling, and relationship building with global healthcare and research buyers.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinical procurement teams | Hospitals, hospital networks, specialty clinics | Evaluate devices, consumables, diagnostics, and service contracts | High-value for respiratory devices, monitoring, testing, and patient-care solutions |
| Pulmonology department leaders | Academic medical centers, tertiary hospitals, specialty institutes | Clinical specification and adoption influence | Key for evidence-backed therapies, diagnostics, and workflow tools |
| Respiratory researchers and lab directors | Universities, research hospitals, research institutes | Influence research tools, lab systems, and trial collaborations | Relevant for research technologies, trial services, and data platforms |
| Hospital operations leaders | Hospitals, integrated delivery networks, care groups | Operational buyers for systems, equipment utilization, and service delivery | Important for workflow efficiency, patient throughput, and service support offerings |
| Respiratory therapists / allied health professionals | Hospitals, rehab centers, outpatient care organizations | Clinical users, product champions, adoption influencers | Strong for hands-on product education and usability-led selling |
| Pharma and biotech teams | Drug developers, specialty pharma, biotech firms | Clinical development, medical affairs, partnership decisions | Relevant for trials, evidence generation, biomarker, and R&D collaborations |
| Public health and government health stakeholders | Ministries of health, public hospitals, agencies | Policy, program, and procurement influence | Important for screening, prevention, and system-level respiratory initiatives |
| Medical device buyers and evaluators | Device distributors, hospitals, clinical engineering teams | Product qualification and purchasing influence | Highly relevant for ventilators, spirometry, oxygen therapy, and monitoring solutions |
| Association leaders and educators | Medical associations, training organizations, professional bodies | Education, advocacy, standards, and program partnerships | Useful for sponsorships, educational content, and CME-related engagement |
| Industry and medical affairs teams | Pharma, medtech, diagnostics, health tech | Scientific exchange, commercial strategy, KOL engagement | Key for conference sponsorships, symposia, and account-based marketing |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Barcelona | Local hospitals, universities, research centers, medical associations | Medium | Local attendance likely includes clinical and academic delegates from the metro area. |
| Host region: Catalonia | Regional healthcare networks, teaching hospitals, health-tech firms | Medium to High | Strong regional medical ecosystem and conference accessibility. |
| Spain | National respiratory specialists, public and private hospitals, ministries, universities | High | Spain is the host country, so national participation should be significant. |
| Nearby European hubs | France, Italy, Portugal, Germany, UK, Benelux, Switzerland | High | Europe-wide scientific participation is a core feature of ERS Congress. |
| Global reach | North America, Middle East, Asia-Pacific, Latin America, Africa | High | ERS states its community spans more than 160 countries, supporting broad international origin. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | ERS describes a community of over 35,000 clinicians, scientists, and allied health professionals from over 160 countries, indicating worldwide audience relevance. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| NHS England | Public healthcare buyer | Large-scale respiratory care, procurement, and health system decision-making relevance | nhs.uk | Procurement Lead, Clinical Procurement Manager, Respiratory Lead | Strong Market Fit, Attendance Not Confirmed |
| Assistance Publique - Hôpitaux de Paris (AP-HP) | Hospital network buyer | Major European hospital system with respiratory service demand | aphp.fr | Director of Procurement, Respiratory Department Head, Medical Device Buyer | Strong Market Fit, Attendance Not Confirmed |
| Charité – Universitätsmedizin Berlin | Academic medical center | Research, clinical practice, and medical technology adoption influence | charite.de | Department Chair, Research Director, Clinical Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Klinikum rechts der Isar, Technical University of Munich | Academic hospital buyer | Respiratory medicine, clinical research, and technology evaluation | mri.tum.de | Head of Pulmonology, Procurement Manager, Research Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Healthcare provider / research institution | Global reputation in respiratory medicine, research, and clinical innovation | mayoclinic.org | Medical Director, Research Administrator, Vendor Management Lead | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic healthcare system | High-value respiratory research and clinical procurement audience | hopkinsmedicine.org | Clinical Procurement Lead, Pulmonary Division Leader, Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Pharma buyer / sponsor-side organization | Respiratory portfolio relevance, medical affairs, and scientific engagement | astrazeneca.com | Medical Affairs Director, Brand Lead, Clinical Development Director | Strong Market Fit, Attendance Not Confirmed |
| Sanofi | Pharma buyer / sponsor-side organization | Potential fit for respiratory, immunology, and clinical education outreach | sanofi.com | Medical Director, Market Access Lead, Partnerships Manager | Strong Market Fit, Attendance Not Confirmed |
| Philips | Medical technology buyer / supplier-side buyer | Respiratory care, monitoring, diagnostics, and hospital technology alignment | philips.com | Business Development Director, Product Manager, Strategic Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| ResMed | Medtech / respiratory solutions provider | Sleep and respiratory care solutions with conference relevance | resmed.com | VP Sales, Product Marketing Director, Regional Business Lead | Strong Market Fit, Attendance Not Confirmed |
| Vyaire Medical | Medical device buyer / supplier-side organization | Ventilation, breathing diagnostics, and respiratory care solutions | vyaire.com | Sales Director, Product Specialist, Clinical Affairs Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Chief Scientific Officer | Executive | C-level | Sets strategy for clinical innovation, research, and partnerships. |
| 2 | Head of Pulmonology / Respiratory Medicine | Clinical | Director / Head | Strong influence on clinical adoption, service needs, and product evaluation. |
| 3 | Director of Procurement / Strategic Sourcing Manager | Procurement | Director / Manager | Decision-maker for vendor selection, purchasing, and contracting. |
| 4 | Clinical Operations Director / Hospital Operations Director | Operations | Director | Influences deployment, workflow, and service implementation. |
| 5 | Medical Affairs Director / Medical Science Liaison Lead | Medical Affairs | Director / Lead | Supports scientific exchange, evidence generation, and KOL engagement. |
| 6 | Research Director / Principal Investigator | Research | Senior | Relevant for trials, research tools, and collaboration opportunities. |
| 7 | Director of Innovation / Digital Health Lead | Innovation / IT | Director / Senior Manager | Evaluates digital tools, remote monitoring, and AI-enabled workflows. |
| 8 | Category Manager / Buyer | Procurement | Manager | Handles sourcing, tendering, and supplier comparisons. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core audience for pulmonary care, procurement, and clinical practice | Hospital decision-makers, department heads, procurement teams |
| 2 | Pharmaceuticals | Respiratory therapeutics, medical affairs, and trials relevance | Medical affairs, brand teams, clinical development |
| 3 | Medical Devices | Ventilation, diagnostics, monitoring, and respiratory equipment | Product adoption, distributor/channel, and clinical education |
| 4 | Biotechnology | Research, biomarkers, and therapeutic innovation | Research collaborations and scientific partnerships |
| 5 | Research | Scientific congress centered on respiratory research and evidence generation | Researchers, trial sponsors, lab solution buyers |
| 6 | Government Administration | Public health policy and health-system procurement involvement | Ministries, public hospital systems, health agencies |
| 7 | Biotechnology | Innovation-heavy buyer and partner segment | KOL engagement, trial collaborations, and licensing discussions |
| 8 | Medical Practice | Pulmonary specialists and physician-led practices | Clinical champions and referral influencers |
| 9 | Information Technology & Services | Digital health, data, interoperability, and remote care solutions | Health IT buyers and integration leads |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unconfirmed | Official event text provided by organizer does not include attendance total | Attendance figure not publicly confirmed by the organizer. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor total provided in supplied official text | Use official exhibitor prospectus or floorplan if needed. |
| Buyer count | Not publicly confirmed | Unconfirmed | No buyer list provided in supplied official text | Likely mixed clinical, academic, and industry audience. |
| Speaker count | Not publicly confirmed | Unconfirmed | Programme available on official website, but count not supplied in text | Use official programme for current verified speaker list. |
| Historical attendance / community scale | 35,000+ community members across 160+ countries | Confirmed community scale | ERS official website | This is community scale, not event-specific attendance. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Respiratory diagnostics | Accurate testing, earlier diagnosis, workflow efficiency | Clinical demos, evidence sessions, comparison tools | Spirometry, imaging support, diagnostic devices, software |
| Patient monitoring | Remote and in-hospital monitoring for chronic disease management | Use-case storytelling and outcomes evidence | Connected devices, telehealth, wearables, dashboards |
| Clinical research | Trials, publications, data quality, biomarker discovery | Research collaboration meetings and investigator outreach | Research platforms, CRO services, analytics, lab tools |
| Therapeutics and drug development | Evidence exchange, KOL access, market education | Symposia, medical affairs outreach, partnering | Pharma products, trial services, scientific communications |
| Digital health | Remote care, patient engagement, data integration | IT and innovation buyer meetings | Health IT, interoperability, analytics, AI tools |
| Medical education | Training, CME, professional development | Faculty sessions and educational sponsorships | Learning platforms, accreditation support, e-learning |
| Procurement and sourcing | Vendor evaluation, cost control, service reliability | Targeted meetings with hospital buying teams | Contracting support, supply services, managed solutions |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The congress attracts clinicians, researchers, hospital leaders, and industry decision-makers with direct respiratory care relevance. |
| Decision-maker availability | High | Strong presence of department heads, medical affairs leaders, procurement stakeholders, and principal investigators. |
| Data collection potential | Medium to High | Good prospecting potential through program, faculty, sponsors, and official event channels; current attendee list not publicly confirmed in the supplied text. |
| Apollo targeting potential | Very High | Clear fit for healthcare, pharma, medtech, research, and public health segments with strong title-based filtering. |
| Geographic targeting potential | High | Barcelona host location supports Spain, EU, and broader international targeting. |
| Best outreach approach | Educational + account-based | Use scientific value propositions, clinical outcomes, and problem-solving messaging. |
| Overall lead quality | High | Excellent event for respiratory-focused prospecting and relationship building. |
| Best use case | Lead generation, sponsor targeting, attendee profiling, and account prioritization | Useful for both event-data sales and B2B outreach to healthcare and life-sciences buyers. |
| Limitations / risks | Attendance list not publicly confirmed in supplied source | Current-year buyer and exhibitor validation may require agenda, sponsor, abstract, or exhibitor-directory review. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Medical Devices; Biotechnology; Research; Government Administration; Information Technology & Services | Prioritize organizations with strong respiratory medicine and procurement relevance. |
| Departments | Procurement, Clinical, Medical Affairs, Research, Operations, Innovation, IT, Partnerships | Reach both decision-makers and technical evaluators. |
| Seniority | Manager, Director, VP, CXO, Head, Principal | Focus on budget owners, clinical leaders, and strategic influencers. |
| Job titles | Chief Medical Officer, Head of Pulmonology, Director of Procurement, Medical Affairs Director, Clinical Operations Director, Research Director, Product Manager, Innovation Lead | Title-based prospecting for the most commercially relevant personas. |
| Geography | Spain, Catalonia, Europe, United Kingdom, France, Germany, Italy, Benelux, Switzerland, United States | Align with host-city pull and international congress reach. |
| Employee size | 201-500, 501-1,000, 1,001-5,000, 5,001-10,000, 10,000+ | Prioritize hospitals, health systems, universities, pharma, and medtech enterprises. |
| Keywords | pulmonology, respiratory medicine, respiratory care, spirometry, ventilation, sleep apnea, chronic respiratory disease, asthma, COPD, medical affairs, clinical research | Improve relevance for event-linked outreach and account discovery. |
| Company type | Public companies, hospitals, universities, research institutes, pharma/medtech firms, government entities | Prioritize large, structured buyers with budget authority and multiple stakeholders. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ERS Congress official website | Official organizer source | Event identity, event description, 2026 dates, city, country, registration status, and organizer context | Very High |
| ERS main website | Official society source | ERS community scale and institutional positioning | Very High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to European Respiratory Society - ERS International Congress — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.